Omeros (OMER) Cash & Current Investments (2010 - 2026)
Omeros recorded quarterly Cash & Current Investments of $135.3 million in Q1 2026, down 21.24% quarter-over-quarter from $171.8 million in Q4 2025, and up 158.18% year-over-year from $52.4 million in Q1 2025.
Omeros' Cash & Current Investments history runs 17 years deep, the most recent figure standing at $135.3 million for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 158.18% year-over-year to $135.3 million; the TTM figure through Mar 2026 stood at $135.3 million (up 158.18% YoY), while the FY2025 annual figure was $171.8 million, up 90.61% from the prior year.
- Cash & Current Investments came in at $135.3 million for Q1 2026 at Omeros, down from $171.8 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $458.8 million in Q1 2024 to a low of $36.1 million in Q3 2025.
- A 5-year average of $214.4 million and a median of $194.9 million in 2022 frame the typical range for Cash & Current Investments.
- Across the five-year window, Cash & Current Investments jumped 488.48% in 2022 and plunged 88.58% in 2025, its largest moves.
- Omeros' Cash & Current Investments stood at $194.9 million in 2022, then slipped by 11.84% to $171.8 million in 2023, then slumped by 47.55% to $90.1 million in 2024, then soared by 90.61% to $171.8 million in 2025, then declined by 21.24% to $135.3 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $135.3 million, $171.8 million, and $36.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 135.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135.32 Mn |
| Dec 31, 2025 | 171.80 Mn |
| Sep 30, 2025 | 36.09 Mn |
| Jun 30, 2025 | 55.54 Mn |
| Mar 31, 2025 | 52.41 Mn |
| Dec 31, 2024 | 90.13 Mn |
| Sep 30, 2024 | 244.84 Mn |
| Jun 30, 2024 | 315.69 Mn |
| Mar 31, 2024 | 458.80 Mn |
| Dec 31, 2023 | 171.85 Mn |
| Sep 30, 2023 | 310.31 Mn |
| Jun 30, 2023 | 341.28 Mn |
| Mar 31, 2023 | 371.33 Mn |
| Dec 31, 2022 | 194.92 Mn |
| Sep 30, 2022 | 296.43 Mn |
| Jun 30, 2022 | 122.53 Mn |
| Mar 31, 2022 | 275.47 Mn |
| Dec 31, 2021 | 157.27 Mn |
| Sep 30, 2021 | 50.37 Mn |
| Jun 30, 2021 | 73.66 Mn |
| Mar 31, 2021 | 100.46 Mn |
| Dec 31, 2020 | 134.95 Mn |
| Sep 30, 2020 | 153.52 Mn |
| Jun 30, 2020 | 16.12 Mn |
| Mar 31, 2020 | 53.96 Mn |
| Dec 31, 2019 | 60.80 Mn |
| Sep 30, 2019 | 27.38 Mn |
| Jun 30, 2019 | 31.86 Mn |
| Mar 31, 2019 | 47.22 Mn |
| Dec 31, 2018 | 60.54 Mn |
| Sep 30, 2018 | 55.16 Mn |
| Jun 30, 2018 | 88.40 Mn |
| Mar 31, 2018 | 72.81 Mn |
| Dec 31, 2017 | 83.75 Mn |
| Sep 30, 2017 | 86.81 Mn |
| Jun 30, 2017 | 29.67 Mn |
| Mar 31, 2017 | 33.65 Mn |
| Dec 31, 2016 | 45.33 Mn |
| Sep 30, 2016 | 47.44 Mn |
| Jun 30, 2016 | 21.24 Mn |
| Mar 31, 2016 | 13.24 Mn |
| Dec 31, 2015 | 28.26 Mn |
| Sep 30, 2015 | 35.00 Mn |
| Jun 30, 2015 | 51.45 Mn |
| Mar 31, 2015 | 70.06 Mn |
| Dec 31, 2014 | 6.89 Mn |
| Sep 30, 2014 | 21.78 Mn |
| Jun 30, 2014 | 37.46 Mn |
| Mar 31, 2014 | 52.19 Mn |
| Dec 31, 2013 | 14.10 Mn |
| Sep 30, 2013 | 9.00 Mn |
| Jun 30, 2013 | 20.06 Mn |
| Mar 31, 2013 | 13.75 Mn |
| Dec 31, 2012 | 22.35 Mn |
| Sep 30, 2012 | 30.63 Mn |
| Jun 30, 2012 | 7.27 Mn |
| Mar 31, 2012 | 17.62 Mn |
| Dec 31, 2011 | 24.57 Mn |
| Sep 30, 2011 | 32.85 Mn |
| Jun 30, 2011 | 36.87 Mn |
| Mar 31, 2011 | 3.92 Mn |
| Dec 31, 2010 | 41.99 Mn |
| Sep 30, 2010 | 2.80 Mn |
| Jun 30, 2010 | 2.87 Mn |